Lisa M. Giles's Net Worth

$1.92 Million

Estimate Recalculated Sep 8, 2024 07:39PM EST

Who is Lisa M. Giles?

Lisa M. Giles has an estimated net worth of $1.92 Million. This is based on reported shares across multiple companies, which include GenMark Diagnostics, Inc., Milestone Pharmaceuticals Inc., HCW Biologics Inc., and Durata Therapeutics, Inc..

SEC CIK

Lisa M. Giles's CIK is 0001568850

Past Insider Trading and Trends

2013 was Lisa M. Giles's most active year for acquiring shares with 3 total transactions. Lisa M. Giles's most active month to acquire stocks was the month of April. 2014 was Lisa M. Giles's most active year for disposing of shares, totalling 5 transactions. Lisa M. Giles's most active month to dispose stocks was the month of October. 2024 saw Lisa M. Giles paying a total of $50,001.00 for 88,215 shares, this is the most they've acquired in one year. In 2021 Lisa M. Giles cashed out on 100,634 shares for a total of $1,961,806.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GenMark Diagnostics, Inc. No price found

Investor

Lisa M. Giles used to own units in Common Stock but no longer holds any shares there. In the year 2015 Lisa M. Giles acquired a total of 81,572 shares in GenMark Diagnostics, Inc., Lisa also disposed a total of 81,572 shares of GenMark Diagnostics, Inc. equalling to $1,961,806.60.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-87.07K
$24.05
-$2,094,081.60
0
Apr 22
Form 4
+10.55%
7.78K
—
—
81.57K
Feb 18
Form 4
+23.06%
13.82K
—
—
73.79K
May 29
Form 4
+0.89%
528
—
—
59.97K
Oct 30
Form 4
+1.20%
702
—
—
59.44K
Jul 31
Form 4
+43.97%
17.94K
—
—
58.73K
May 31
Form 4
+72.21%
17.11K
—
—
40.8K
May 24
Form 4
+41.78%
6.98K
—
—
23.69K
May 25
Form 4/A
+3.33%
177
$9.40
$1,663.80
5.5K
Aug 12
Form 4
+18.29%
823
$9.40
$7,736.20
5.32K
Aug 12
Form 4
+103.46%
8.5K
—
—
16.71K
May 26
Form 4
+800.00%
4K
$6.60
$26,400.00
4.5K
Nov 3
Form 4
+374.74%
6.48K
—
—
8.21K
May 28
Form 4
∞
1.73K
—
—
1.73K
Feb 19
Form 3
—
0
—
—
0
No matching records found

Milestone Pharmaceuticals Inc. (MIST) Snapshot price: $1.46

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 28
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jul 5
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Oct 1
Form 3
—
0
—
—
0
No matching records found

HCW Biologics Inc. (HCWB) Snapshot price: $0.6656

Investor

Lisa M. Giles owns 35,815 units of Common Stock which is worth $23,838.46. From 2021 to 2024 Lisa M. Giles acquired a total of 35,715 shares in HCW Biologics Inc. at a cost of $50,001.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 14
Form 4
+35,715.00%
35.72K
$1.40
$50,001.00
35.81K
Feb 20
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Oct 26
Form 3
—
0
—
—
0
No matching records found

Durata Therapeutics, Inc. No price found

Investor

Lisa M. Giles used to own units in Common Stock but no longer holds any shares there. In the year 2013 Lisa M. Giles filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.50K
—
—
0
Nov 17
Form 4
—
0
—
—
0
May 21
Form 4
+50.00%
500
$8.25
$4,125.00
1.5K
Aug 6
Form 3/A
—
0
—
—
0
Form 4
∞
1K
$10.95
$10,950.00
1K
Dec 3
Form 4
—
0
—
—
0
May 16
Form 3
—
0
—
—
0
No matching records found